Figure 2. Enzymatic degradation of RNA induces aggregation of proteins associated with neurodegenerative diseases.

• A, B
  Western blot analysis of soluble and aggregated proteins after RNase treatment of lysate from human neurons (A), or HEK293T cells expressing GFP‐Aβ or GFP (B).
• C
  Effect of an RNase A inhibitor (RNasin) on RNase A mediated protein aggregation in neuronal cell lysate.